PCI for Bifurcation Coronary Lesion

Similar documents
LM stenting - Cypher

Protection of side branch is essential in treating bifurcation lesions: overview

Drug Eluting Stents: Bifurcation and Left Main Approach

Contemporary therapy of bifurcation lesions

Percutaneous Intervention of Unprotected Left Main Disease

In-Stent Restenosis. Can we kill it?

PCI for Chronic Total Occlusions

PCI for In-Stent Restenosis. CardioVascular Research Foundation

A Paclitaxel-Eluting Balloon for Bifurcation Lesions : Early Clinical Observations

ANGIOPLASY SUMMIT 2007 TCT ASIA PACIFIC. Seoul, Korea: April Session: Left mains & bifurcation intervention

PCI for Left Anterior Descending Artery Ostial Stenosis

DES In-stent Restenosis

Unprotected LM intervention

PCI for Long Coronary Lesion

FFR-guided Jailed Side Branch Intervention

Stent Thrombosis in Bifurcation Stenting

Why I try to avoid side branch dilatation

Yves Louvard, Thierry Lefèvre, Marie-Claude Morice

Non-LM bifurcation studies of importance in 2011

Eulogio Garcia MD H. U. Gregorio Marañon Madrid

The Spectrum of Dedicated Stents for Bifurcation Lesions: Current Status and Future Projections. Martin B. Leon, MD

Perspective of LM stenting with Current registry and Randomized Clinical Data

Final Kissing Ballooning Returns? The analysis of COBIS II registry

Sunao Nakamura M.D,Ph.D.

ΣΥΜΠΛΟΚΕΣ ΑΓΓΕΙΟΠΛΑΣΤΙΚΕΣ ΑΓΓΕΙΟΠΛΑΣΤΙΚΗ ΔΙΧΑΣΜΩΝ

Lesions at coronary bifurcations represent a challenging

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial

IVUS Assessment of the Mechanism of In-stent Restenosis? Gary S. Mintz, MD Cardiovascular Research Foundation

Complex Coronary Interventions: Bifurcations. John M. Lasala MD PhD Professor of Medicine Washington University St Louis, Missouri

Welcome to the 8 th European Bifurcation Club October Barcelona

Management of Non-protected Left-Main Bifurcation without Drug Eluting Stent. Masahiko Ochiai MD, FACC, FESC, FSCAI

DEB experience in Gachon Universtiy Gil Hospital (in ISR) Soon Yong Suh MD., PhD. Heart Center Gachon University Gil Hospital Seoul, Korea.

PCI for Chronic Total Occlusions

Final Clinical and Angiographic Results From a Nationwide Registry of FIREBIRD Sirolimus- Eluting Stent: Firebird In China (FIC) Registry (PI R. Gao)

Left Main PCI. Integrated Use of IVUS and FFR. Seung-Jung Park, MD, PhD

6 th European Bifurcation Club October BUDAPEST. Kissing in simple strategy? Why and how I kiss. Y. Louvard, ICPS, Massy France

DES in Diabetic Patients

Incidence and Treatment for LM In-Stent

Drug eluting stents. Where are we now and what can we expect in 2003? Tony Gershlick Leicester

2010 Korean Society of Cardiology Spring Scientific Session Korea Japan Joint Symposium. Seoul National University Hospital Cardiovascular Center

RESTENOSIS Facing up to the problem

Komplexe Koronarintervention heute: Von Syntax zu bioresorbierbaren Stents

Integrated Use of IVUS and FFR for LM Stenting

CTO Re vascularization in 2013

Seeing double: the double kissing crush stenting technique for coronary bifurcation lesions

The Tryton Side Branch System in Distal Left Main PCI

PCI for Ostial Lesion

Technical considerations in the Treatment of Left Main Lesions Ioannis Iakovou, MD, PhD

Bench Insights into Bifurcation Stenting in the DES Era: An Update

Unprotected Left Main Stenting: Patient Selection and Recent Experience. Alaide Chieffo. S. Raffaele Hospital, Milan, Italy

Rationale for Percutaneous Revascularization ESC 2011

Count Down to COMBAT

IVUS-Guided d Provisional i Stenting: Plaque or Carina Shift. Soo-Jin Kang, MD., PhD.

Upgrade of Recommendation

Interventional Cardiology חיים דננברג מערך הלב

Long-term freedom from angina and

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions

Index. Note: Page numbers of article titles are in boldface type.

in an Unyielding Patient Dr Jason See, Dr Goh Yew Seong, Dr Rohit Khurana Changi General Hospital Singapore

Bifurcation Stenting: IVUS and OCT Information

Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program

Clinical Considerations for CTO

DK Crush,Culotte,SKS,T or TAP. Subhash Chandra, MD,DM,FACC Chairman,Cardiac Sciences BLK Super Speciality Hospital, Pusa Road, New Delhi

EBC London 2013 Provisional SB stenting strategy with kissing balloon with Absorb

DRUG-COATED BALLOONS AND CORONARY BIFURCATION LESIONS

I have nothing to disclose.

Kurdistan Technique for the Treatment of Unprotected Trifurcation Left Main Stem Coronary Artery Lesion: Case Report

Prevention of Coronary Stent Thrombosis and Restenosis

Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome

LCX. President / Director of Cardiology / New Tokyo Hospital

Strategies for PCI of SVG

Side Branch Occlusion

DESolve NX Trial Clinical and Imaging Results

IVUS vs FFR Debate: IVUS-Guided PCI

DISCOVER Ultimaster with Optical Frequency Domain Imaging

Efficacy of DEB in Calcification and Subintimal Angioplasty

Bifurcation Stenting. European Bifurcation Club update. Ioannis Iakovou, MD Onassis Cardiac Surgery Center Athens, Greece

PCI with DEB only for Bifurcation Lesions

Are Asian Patients Different? - Updates Of Biomatrix Experience In Regional Settings: BEACON II (3 Yr F up) &

Bifurcations Bad Krozingen I

Left Main and Bifurcation Summit I. Lessons from European LM Studies

Important LM bifurcation studies update

Basics of Angiographic Interpretation Analysis of Angiography

ΑΝΤΙΓΝΩΜΙΕΣ ΣΤΗΝ ΕΠΕΜΒΑΤΙΚΗ ΚΑΡΔΙΟΛΟΓΙΑ:Νόσος στελέχους Αγγειοπλαστική

Insight from the CACTUS trial Coronary Bifurcation Application of the Crush

Michael Mack, M.D. Baylor Healthcare System Heart Hospital Baylor Plano Dallas, TX

Nobori Clinical Studies Up-dates. Gian Battista DANZI, M.D. Ospedale Maggiore Policlinico University of Milan, Italy

BIOFREEDOM: Polymer free Biolimus A9 eluting

C. W. Hamm, B. Cremers, H. Moellmann, S. Möbius-Winkler, U. Zeymer, M. Vrolix, S. Schneider, U. Dietz, M. Böhm, B. Scheller

Complex PCI of an LAD/Diagonal bifurcation lesion (Medina 1,1,1) utilizing the DK Crush technique ".

Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion

Provisional T- sten/ng Future Outlook: Ra/onale of Plaque Incision + DCB

Complex PCI. Your partner in complex PCI: In-stent restenosis (ISR)

IN-STENT RESTENOSIS. K.Boerlage-van Dijk CarVasZ 2014

OCTOBER. OCT Optimised Bifurcation Event Reduction. A Nordic Baltic British clinical outcome trial

Journal of the American College of Cardiology Vol. 47, No. 8, by the American College of Cardiology Foundation ISSN /06/$32.

ANGIOPLASY SUMMIT 2007 TCT ASIA PACIFIC. Seoul, Korea: April The problem is exaggerated: Data from Real World Registries

Late Loss Is The Single Best Parameter For Estimating Stent-Based Restenosis Resistance

SFA In-stent Restenosis

What Coronary Specialists Teach The Vascular Community About Vessel Prep? Tony Das, MD Texas Health, Dallas Dallas, Texas

Transcription:

PCI for Bifurcation Coronary Lesion

Bifurcation Lesions PCI is Challenging Higher acute complication Lower success rates Higher restenosis & TLR Restenosis Rate 21 ~ 57% TLR 8 ~ 43%

Event Free Survival after PCI NHLBI Registry % event free 100 90 80 70 60 Bifurcation ( ), n=2115 Bifurcation (+), n=321 74.3% 67.9% 0 1 2 3 4 5 6 7 8 9 10 11 12 Duration (months) * P < 0.05 Suwaidi J, et al. AJC 2001;87:1139-44

Side Branch Loss Main Mechanism of Adverse Outcomes

Predictors of Side Branch Occlusion Side branch DS > 50 % Disease burden in parent vessel at take-off of side branch Dissection of parent vessel

How to Stent? Stenting Technique

Single Stenting Single stenting in the parent vessel with or without balloon dilatation in the side branch Main vessel Side branch

Two Stenting : T Stenting Sequential stenting in the main vessel and the side branch Main vessel Side branch

Two Stenting : Y (Culotte) Stenting Stenting in the side branch followed by in the main vessel Main vessel Side branch

Two Stenting : Kissing Stenting Simultaneous stenting in the main vessel and the side branch Main vessel Side branch

Single Stent vs. Two Stent Procedural Results Single (n=39) Double (n=53) P Ref. vessel(mm) 3.0 ± 0.4 3.1 ± 0.6 NS Kissing balloon (%) 56 92 < 0.05 Procedural time (min) 98 ± 45 127 ± 52 < 0.05 Success (%) 92 87 NS In-hosp. MACE (%) 0 13 < 0.05 Yamashita T, et al. JACC 2000;35:1145-51

Single Stent vs. Two Stent 6 Month Restenosis Rate P=NS 38 43 Single Double 13 25 13 28 % Main vessel Side branch Global Anzuini A, et al. Am J Cardiol 2001;88:1246-50

Single Stent vs. Two Stent Event Free Survival Freedom from death, MI, CABG, reptca & severe angina % 100 80 Stent+PTCA 100 80 T-stenting 60 40 Stent+Stent 60 40 Y-stenting 20 *P=0.106 20 *P=0.004 0 3 6 9 12 0 3 6 9 12 Months Months Suwaidi J, et al. JACC 2000;35:929-36

Tube Stent vs. Coil Stent Side Branch Occlusion (%) AMC Data P = NS CrossFlex (Coil) NIR (Tube) GFX (Hybrid) 7.7 10.5 8.8 0 1.8 1.3 Post-Balloon Post-Stent Cho GY, et al. Cathet Cardiovasc intervent 2001;52:18-23

Two bare metal stents are not better than single stent. Stent in main vessel and POBA in side branch with Optional kissing balloon

Importance of Stenting Technique Period Period (n=182) (n=191) P Tube stent (main vessel) Final Kissing balloon Both branch stent 6 Fr catheter MACE TVR(7 months) 59 % 18 % 73 % 29 % 21 % 94 % 75 % 30 % 93 % 17 % 14 % < 0.01 < 0.001 < 0.01 < 0.01 < 0.05 Lefevre T, et al. Cathet Cardiovasc Intervent 2000 ;49:274-83

Plaque Reduction in Main Vessel? Debulking Atherectomy

Role of DCA before Stenting Minimal Lumen Diameter DCA + S (n=58) Stent alone (n=332) P Main Vessel MLD post (mm) MLD F/U (mm) Side Branch MLD post (mm) MLD F/U (mm 3.2 0.5 2.2 1.1 2.4 0.5 1.6 0.7 3.0 0.6 1.6 0.9 2.0 0.6 1.2 0.7 0.01 0.01 0.01 0.03 Chieffo A, et al. Am J Cardiol 2002;90:44H

Role of DCA before Stenting Restenosis rate (%) MACE (%) DCA+Stent Stent alone *P < 0.05 41 34 * * P < 0.05 16 16 14 32 Main vessel Side branch Chieffo A, et al. Am J Cardiol 2002;90:44H

Subgroup of AMIGO Trial Restenosis Rate 25 20 15 10 5 0 P < 0.05 9.8 % 4/45 DCA+Stent 20.9 % 9/43 Stent alone Braden G, et al. TCT 2002

Debulking Followed By Stenting Might be beneficial in lesions with large plaque burden

New Modality for Bifurcation Lesion? True Bifurcated Stent Drug Eluting Stent

Bifurcated Stents NIRSIDE Stent Guidant Frontier Stent BARD Bifurcate XT

Bifurcated Stent Cordis DBS Stent 34 patients (mean 64 years) Technical Success 94% MACE @ 30 days 0% Restenosis @ 6 Mo 33% TLR 19% Dibie A, et al. Am J Cardiol 2002;90:13H

Bifurcated Stents AST SLK -View Side hole Stent length = 17mm Catheter length = 140 cm Crossing profile = 0.055 IN Available in two sizes - 3.0mm with 2.5mm side hole - 3.5mm with 3.0mm side hole

Bifurcated Stents AST SLK -View Main catheter system comprises of a main stent with a side hole and a stabilizing catheter, which allows access to side branch after stenting

AST SLK-View Stent AMC Experience 48 pts (mean 58 years) 50 lesions Technical Success Side branch accessibility Side branch preservation after stenting Parent vessel 100 % Side branch 100 % 100 % 100 % Kim YH, et al. TCT 2002

Drug Eluting Stent

SIRIUS Bifurcation Study Sirolimus Eluting Stent Total 86 pts enrolled Randomization Stent + Stent 43 pts Cross-over 2 Cross-over 22 Stent + PTCA 43 pts 1 without success Stent + Stent 63 pts(65les) Stent + PTCA 22 pts A Colombo, et al. AHA 2002

Procedural Technique SIRIUS Bifurcation Study Technique T- stenting Side branch first Main vessel first V- stenting Y- stenting Kissing balloon GP b/ a inhibitor Stent / Stent (n=63) 60 40 20 1 2 60 (95%) 27 (43%) Stent / PTCA (n=22) 19 (86%) 8 (37%) A Colombo, et al. AHA 2002

Main Vessel Minimal Lumen Diameter SIRIUS Bifurcation mm 2.5 2 1.5 1 0.5 0 0.99 (n=63) 0.92 (n=22) Baseline Stent+Stent 2.4 (n=46) 2.5 (n=19) Follow-up Stent+PTCA

Side Branch Minimal Lumen Diameter SIRIUS Bifurcation mm 1.6 1.4 1.2 1 0.8 P=0.02 1.58 (n=44) 1.56 (n=18) 0.6 0.4 0.2 1.14 0.88 (n=22) (n=65) 0 Baseline Follow-up Stent+Stent Stent+PTCA

In-Segment Restenosis SIRIUS Bifurcation % 30 25 20 15 25.0 P=0.20 10.0 10 5 2.3 5.0 0 Main Vessel Stent+Stent Side Branch Stent+PTCA

6 Months Restenosis Rate SIRIUS Bifurcation Ostium of the side branch Distal to the stent Proximal to the stent Main, S+S (n=1) 0 0 1 Main, S+P (n=1) 0 0 1 Side, S+S (n=11) 10 1 0 Side, S+P (n=2) 2 0 0

What We Learned DES In Bifurcation Lesion Effective Nearly eliminate restenosis in the main vessel Ineffective Persistent disturbingly high restenosis at the uncovered side branch ostium

Two Stenting Strategy in SIRIUS Bifurcation Study Potential gap susceptible to restenosis

Proposed Stenting Strategy In the Era of DES Complete coverage of side branch ostium Modified T Y (Culotte) Kissing

Emerging New Technique Stent-Crush Crushed first stent implanted in side branch

AMC Proposal Kissing Stenting with Optional Stent-Crush Suboptimal result after kissing stenting

Future Perspectives in the Era of DES Following consideration should be evaluated The role of debulking atherectomy The fate of side branch after PCI with DES Large randomized comparison of two DES and single DES